Skip to main content

Biocryst Pharmaceuticals Inc 10-Q for FY2026 Q1

Biocryst Pharmaceuticals Inc (BCRX)

10-Q 2026-05-06 For: 2026-03-31
View Original
Added on May 06, 2026

About this 10-Q

Biocryst Pharmaceuticals Inc filed this 10-Q on May 6, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$156.41M
up 7.5% from $145.53M a year earlier
Net loss
$721.81M
compared with net income of $32K a year earlier
Diluted EPS
-$2.98
compared with $0.00 a year earlier